IS3994A - Hliðstæð aðferð til framleiðslu á indole afleiðum - Google Patents

Hliðstæð aðferð til framleiðslu á indole afleiðum

Info

Publication number
IS3994A
IS3994A IS3994A IS3994A IS3994A IS 3994 A IS3994 A IS 3994A IS 3994 A IS3994 A IS 3994A IS 3994 A IS3994 A IS 3994A IS 3994 A IS3994 A IS 3994A
Authority
IS
Iceland
Prior art keywords
production
indole derivatives
analogous method
analogous
indole
Prior art date
Application number
IS3994A
Other languages
English (en)
Inventor
Cugola Alfredo
Gaviraghi Giovanni
Giacobbe Simone
Original Assignee
Glaxo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Spa filed Critical Glaxo Spa
Publication of IS3994A publication Critical patent/IS3994A/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
IS3994A 1992-04-16 1993-04-15 Hliðstæð aðferð til framleiðslu á indole afleiðum IS3994A (is)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929208492A GB9208492D0 (en) 1992-04-16 1992-04-16 Heterocyclic compounds

Publications (1)

Publication Number Publication Date
IS3994A true IS3994A (is) 1993-10-17

Family

ID=10714220

Family Applications (1)

Application Number Title Priority Date Filing Date
IS3994A IS3994A (is) 1992-04-16 1993-04-15 Hliðstæð aðferð til framleiðslu á indole afleiðum

Country Status (41)

Country Link
US (4) US5374649A (is)
EP (1) EP0568136A1 (is)
JP (2) JPH07505407A (is)
KR (1) KR100264114B1 (is)
CN (1) CN1042331C (is)
AP (1) AP480A (is)
AT (1) AT403917B (is)
AU (1) AU666927B2 (is)
BE (1) BE1006343A5 (is)
BG (1) BG62136B1 (is)
BR (1) BR1100323A (is)
CA (3) CA2094076A1 (is)
CH (1) CH685630A5 (is)
CY (1) CY2038B1 (is)
CZ (1) CZ285799B6 (is)
DK (1) DK169890B1 (is)
ES (1) ES2105924B1 (is)
FI (1) FI106198B (is)
FR (1) FR2690919B1 (is)
GB (2) GB9208492D0 (is)
GE (1) GEP19991704B (is)
GR (1) GR1001619B (is)
HK (1) HK95797A (is)
HU (2) HU217964B (is)
IL (1) IL105412A (is)
IS (1) IS3994A (is)
IT (1) IT1265325B1 (is)
LU (1) LU88248A1 (is)
MX (1) MX9302195A (is)
MY (1) MY112232A (is)
NO (1) NO301879B1 (is)
NZ (1) NZ247413A (is)
OA (1) OA10103A (is)
PL (1) PL176451B1 (is)
RO (1) RO113242B1 (is)
RU (1) RU2129544C1 (is)
SE (1) SE504336C2 (is)
SK (1) SK281941B6 (is)
TW (1) TW224457B (is)
WO (1) WO1993021153A1 (is)
ZA (1) ZA932642B (is)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9304500D0 (en) * 1993-03-05 1993-04-21 Glaxo Spa Heterocyclic compounds
US5519048A (en) * 1993-05-27 1996-05-21 Merrell Pharmaceuticals Inc. 3-(indol-3-yl)-propenoic acid derivatives and pharmaceutical compositions thereof
ATE151750T1 (de) * 1993-05-27 1997-05-15 Merrell Pharma Inc 3-(indol-3-yl) propensäurderivate, die als nmda- antagonisten nützlich sind
GB9319243D0 (en) * 1993-09-17 1993-11-03 Glaxo Spa Heterocyclic compounds
GB9321221D0 (en) * 1993-10-14 1993-12-01 Glaxo Spa Heterocyclic compounds
TW280819B (is) * 1993-11-17 1996-07-11 Sumitomo Pharma
US5563157B1 (en) * 1994-10-31 1999-02-02 Hoecst Marion Roussel Inc Heterocycle substituted propenoic acid derivatives and pharmaceutical compositions thereof
GB9502695D0 (en) * 1995-02-11 1995-03-29 Glaxo Spa Pharmaceutical composition
GB9504361D0 (en) * 1995-03-04 1995-04-26 Glaxo Spa Heterocyclic compounds
AU4416197A (en) * 1996-09-17 1998-04-14 Regents Of The University Of California, The Positive ampa receptor modulation to enhance brain neurotrophic factor expression
BR9712144A (pt) * 1996-09-30 1999-08-31 Hoechst Marion Roussel Inc Novos antagonistas de nmda (d- aspartato de n-metila).
US5922752A (en) * 1997-06-11 1999-07-13 Hoechst Marion Roussell, Inc. NMDA (n-methyl-d-aspartate) antagonists
TR200002771T2 (tr) * 1998-03-26 2001-02-21 Fujisawa Pharmaceutical Co.,Ltd. Devamlı salımı olan preparatlar
US20030162825A1 (en) * 2001-11-09 2003-08-28 Sepracor Inc. D-amino acid oxidase inhibitors for learning and memory
JP2005518371A (ja) * 2001-12-10 2005-06-23 アムジエン・インコーポレーテツド バニロイド受容体リガンド及び治療に於けるこれらの使用
PA8579701A1 (es) * 2002-08-23 2005-05-24 Pfizer Prod Inc Profarmaco inhibidor de beta-lactamasa
DE10306202A1 (de) 2003-02-13 2004-08-26 Grünenthal GmbH Arzneimittel enthaltend substituierte 2-Aryl-Aminoessigsäure-Verbindungen und/oder substituierte 2-Heteroaryl-Aminoessigsäure-Verbindungen
WO2004108733A1 (en) * 2003-06-05 2004-12-16 Pfizer Products Inc. Beta-lactamase inhibitor prodrug
WO2005051919A1 (en) * 2003-11-26 2005-06-09 Pfizer Products Inc. Aminopyrazole derivatives as gsk-3 inhibitors
RU2361862C2 (ru) * 2003-12-29 2009-07-20 Сепракор Инк. Пиррольные и пиразольные ингибиторы daao
US20060002999A1 (en) * 2004-06-17 2006-01-05 Forest Laboratories, Inc. Immediate release formulations of 1-aminocyclohexane compounds, memantine and neramexane
CN101553217A (zh) 2005-07-06 2009-10-07 塞普拉科公司 艾司佐匹克隆与反式4－(3,4－二氯苯基)－1,2,3,4－四氢－n－甲基－1－萘胺或反式4－(3,4－二氯苯基)－1,2,3,4－四氢－1－萘胺的组合以及治疗绝经期和心境障碍、焦虑症和认知障碍的方法
NZ569608A (en) * 2006-01-06 2011-09-30 Sepracor Inc Tetralone-based monoamine reuptake inhibitors
AU2007205114B2 (en) * 2006-01-06 2012-11-08 Sunovion Pharmaceuticals Inc. Cycloalkylamines as monoamine reuptake inhibitors
CN101421228B (zh) 2006-03-31 2014-05-21 塞普拉柯公司 手性酰胺和胺的制备
US7579370B2 (en) * 2006-06-30 2009-08-25 Sepracor Inc. Fused heterocycles
US7884124B2 (en) * 2006-06-30 2011-02-08 Sepracor Inc. Fluoro-substituted inhibitors of D-amino acid oxidase
US20080082066A1 (en) * 2006-10-02 2008-04-03 Weyerhaeuser Co. Crosslinked carboxyalkyl cellulose fibers having non-permanent and temporary crosslinks
EP1942104A1 (en) 2006-12-20 2008-07-09 sanofi-aventis Heteroarylcyclopropanecarboxamides and their use as pharmaceuticals
US7902252B2 (en) * 2007-01-18 2011-03-08 Sepracor, Inc. Inhibitors of D-amino acid oxidase
US20090099248A1 (en) * 2007-01-18 2009-04-16 Sepracor Inc. Inhibitors of d-amino acid oxidase
KR101581289B1 (ko) 2007-05-31 2015-12-31 세프라코 아이엔시. 모노아민 재흡수 억제제로서 페닐 치환된 시클로알킬아민
WO2009151498A2 (en) * 2008-03-28 2009-12-17 Forest Laboratories Holdings Limited Memantine formulations
WO2010017418A1 (en) * 2008-08-07 2010-02-11 Sepracor Inc. Prodrugs of fused heterocyclic inhibitors of d-amino acid oxidase
US20110319463A1 (en) * 2009-03-10 2011-12-29 Saten Pharamaceuticals Co., Ltd. Preventive or therapeutic agents for optic nerve disorders comprising 4,6-dichloro-1h-indole-2-carboxylic acid derivatives or salts thereof as active ingredients
WO2011017634A2 (en) * 2009-08-07 2011-02-10 Sepracore Inc. Prodrugs of fused heterocyclic inhibitors of d-amino acid oxidase
US9737531B2 (en) 2012-07-12 2017-08-22 Glytech, Llc Composition and method for treatment of depression and psychosis in humans
AU2015253099B2 (en) 2014-04-30 2019-07-18 National Chiao Tung University Use of known compounds as D-amino acid oxidase inhibitors
IL307576A (en) 2016-09-14 2023-12-01 Yufeng Jane Tseng Novel mutated benzimidazoles as D-amino acid oxidase (DAAO) inhibitors
CA3067162A1 (en) 2017-06-12 2018-12-20 Glytech Llc. Treatment of depression with nmda antagonists and d2/5ht2a or selective 5ht2a antagonists
CN112707874A (zh) * 2020-12-29 2021-04-27 广东中科药物研究有限公司 一种抗病毒化合物及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3010971A (en) * 1960-08-04 1961-11-28 Smith Kline French Lab Cyclopropylamine derivatives and processes for their preparation
DK500285A (da) * 1984-11-02 1986-05-03 Glaxo Group Ltd Cephalosporinantibiotika
US4960786A (en) * 1989-04-24 1990-10-02 Merrell Dow Pharmaceuticals Inc. Excitatory amino acid antagonists
PT93943A (pt) * 1989-05-05 1991-02-08 Searle & Co Processo para a preparacao de composicoes contendo compostos indole-2-carboxilato para tratamento de perturbacoes do snc
CA2087091C (en) * 1990-07-16 2001-09-11 Francesco G. Salituro Excitatory amino acid antagonists
US5284862A (en) * 1991-03-18 1994-02-08 Warner-Lambert Company Derivatives of 2-carboxyindoles having pharmaceutical activity
US5145845A (en) * 1991-05-14 1992-09-08 Warner-Lambert Co. Substituted 2-carboxylindoles having pharmaceutical activity

Also Published As

Publication number Publication date
GB9208492D0 (en) 1992-06-03
GR1001619B (el) 1994-07-29
US5510367A (en) 1996-04-23
FI944800A (fi) 1994-10-12
BR1100323A (pt) 2000-06-27
KR100264114B1 (ko) 2000-11-01
ES2105924A1 (es) 1997-10-16
CA2094075A1 (en) 1993-10-17
RU94045915A (ru) 1996-09-10
FR2690919B1 (fr) 1995-05-05
PL176451B1 (pl) 1999-05-31
EP0568136A1 (en) 1993-11-03
BG99111A (bg) 1995-05-31
ITRM930236A0 (it) 1993-04-15
NO943913L (no) 1994-12-14
BE1006343A5 (fr) 1994-07-26
AP9300524A0 (en) 1993-04-30
GB2266091A (en) 1993-10-20
TW224457B (is) 1994-06-01
OA10103A (en) 1996-12-18
RO113242B1 (ro) 1998-05-29
NO301879B1 (no) 1997-12-22
BG62136B1 (bg) 1999-03-31
GB2266091B (en) 1995-08-09
CN1042331C (zh) 1999-03-03
HK95797A (en) 1997-08-08
FI106198B (fi) 2000-12-15
SK281941B6 (sk) 2001-09-11
CN1085212A (zh) 1994-04-13
DK43193D0 (da) 1993-04-15
SE9301241L (sv) 1993-10-17
AU666927B2 (en) 1996-02-29
GB9307808D0 (en) 1993-06-02
DK169890B1 (da) 1995-03-27
RU2129544C1 (ru) 1999-04-27
JPH07505407A (ja) 1995-06-15
CH685630A5 (fr) 1995-08-31
DK43193A (da) 1993-10-17
LU88248A1 (fr) 1994-03-01
CZ285799B6 (cs) 1999-11-17
HU9402975D0 (en) 1995-02-28
ES2105924B1 (es) 1998-07-01
ITRM930236A1 (it) 1994-10-15
AT403917B (de) 1998-06-25
AU3692393A (en) 1993-10-21
CA2094073A1 (en) 1993-10-17
US5374649A (en) 1994-12-20
SE504336C2 (sv) 1997-01-13
CY2038B1 (en) 1998-04-30
HU211826A9 (en) 1995-12-28
MY112232A (en) 2001-05-31
JPH0649027A (ja) 1994-02-22
FI944800A0 (fi) 1994-10-12
NO943913D0 (no) 1994-10-14
NZ247413A (en) 1995-12-21
FR2690919A1 (fr) 1993-11-12
CA2094076A1 (en) 1993-10-17
SK124194A3 (en) 1995-05-10
HUT70526A (en) 1995-10-30
IT1265325B1 (it) 1996-10-31
IL105412A (en) 1998-02-22
IL105412A0 (en) 1993-08-18
MX9302195A (es) 1994-03-31
AP480A (en) 1996-03-22
ATA75293A (de) 1997-11-15
HU217964B (hu) 2000-05-28
SE9301241D0 (sv) 1993-04-15
US5374648A (en) 1994-12-20
GEP19991704B (en) 1999-08-05
WO1993021153A1 (en) 1993-10-28
ZA932642B (en) 1994-01-10
US5373018A (en) 1994-12-13
CZ254394A3 (en) 1995-07-12

Similar Documents

Publication Publication Date Title
IS3994A (is) Hliðstæð aðferð til framleiðslu á indole afleiðum
IS3873A (is) Hliðstæð aðferð til framleiðslu á kristölluðum oxaþíólan afleiðum
IS4148A (is) Hliðstæð aðferð til framleiðslu á 1,5 Benzodiazepine afleiðum
IS4201A (is) Aðferð til framleiðslu á Benzofuran afleiðum
IS3970A (is) Hliðstæð aðferð til framleiðslu á 1,5-benzódíazepín afleiðum
IS3936A (is) Hliðstæð aðferð til framleiðslu á vatnsuppleysanlegum kamptóþesín afleiðum
IS3871A (is) Hliðstæðar aðferðir til framleiðslu á Quinuclidine afleiðum
IS3954A (is) Hliðstæð aðferð við framleiðslu nýrra peptíðafleiða
IS3915A (is) Aðferð til framleiðslu á benzanilíð afleiðum
IS3914A (is) Aðferð til framleiðslu á benzanilíð afleiðum
IS4121A (is) Hliðstæð aðferð til framleiðslu á 2,6-Díamínópúrín afleiðum
IS4219A (is) Aðferð til framleiðslu á Indole afleiðum
IS3945A (is) Aðferð til framleiðslu á ediksýruafleiðum
IS3809A (is) Hliðstæð aðferð við framleiðslu nýrra sykursteraestera
IS4244A (is) Aðferð til framleiðslu á Indoline afleiðum og notkun þeirra
IS3827A (is) Hliðstæð aðferð við framleiðslu á pýrról[2,3 b]pýridínum
IS4190A (is) Hliðstæð aðferð til framleiðslu á 1,5 bensódíasepín afleiðum
IS4980A (is) Aðferðir og milliefni við framleiðslu á setnum krómanól afleiðum
IS4033A (is) Hliðstæð aðferð til framleiðslu á isobenzofuranylafleiðum og milliefni til notkunar með aðferðinni
IS4079A (is) Milliefni til framleiðslu á súbstitúeruðum bensimidasólum
ZA985918B (en) Process for the production of indole derivatives.
FI953361A (fi) Menetelmä substituoitujen indolonijohdannaisten valmistamiseksi
IS4707A (is) Aðferð til framleiðslu á díoxóazabísýklóhexönum
IS4055A (is) Aðferð til framleiðslu á Lactam afleiðum
FI931845A (fi) Anordning och foerfarande foer kylning av hett fast aemne i virvelbaedd